by According to Precedence Research, during the forecast period of 2022 to 2030, the global pharmaceutical excipients market is estimated to develop at a compound annual growth rate (CAGR) of 5.39%. The global pharmaceutical excipients market was valued at USD 8.85 billion in 2021, and it is predicted to exceed USD 14.2 billion by 2030. The study investigates several elements and their consequences on the growth of the pharmaceutical excipients market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1761
This report focuses on pharmaceutical excipients market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall pharmaceutical excipients market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Pharmaceutical Excipients Market
| Report Coverage | Details |
| Market Size by 2030 | USD 14.2 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.39% |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Functionality, Formulations, End-Users, Distribution Channel, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of pharmaceutical excipients, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of pharmaceutical excipients has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the pharmaceutical excipients market.
Some of the prominent players in the pharmaceutical excipients market include:
- Ashland Global Holdings
- BASF SE
- DuPont
- Roquette Feres
- Evonik Industries AG
- Associated British Foods
- Archer Daniels Midland Company
- Lubrizol Corporation
- Croda International
- Kerry Group
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1761
Segments Covered in the Report
By Product
- Organic Chemicals
- Inorganic Chemicals
- Others
By Functionality
- Fillers and Diluents
- Suspending and Viscosity Agents
- Coating Agents
- Binders
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Flavoring Agents and Sweeteners
- Other Functionalities
By Formulations
- Topical Formulations
- Oral Formulations
- Parenteral Formulations
- Other Formulations
By End-Users
- Pharmaceuticals Companies
- Research Organization
- Academics
- Others
By Distribution Channel
- Online Pharmacy
- Retail
- Mail-Order
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Excipients Market
5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Excipients Market, By Product
8.1. Pharmaceutical Excipients Market, by Product, 2022-2030
8.1.1. Organic Chemicals
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Inorganic Chemicals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmaceutical Excipients Market, By Functionality
9.1. Pharmaceutical Excipients Market, by Functionality, 2022-2030
9.1.1. Fillers and Diluents
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Suspending and Viscosity Agents
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Coating Agents
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Binders
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Disintegrants
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Colorants
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Lubricants and Glidants
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Preservatives
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Emulsifying Agents
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Flavoring Agents and Sweeteners
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Other Functionalities
9.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmaceutical Excipients Market, By Formulations
10.1. Pharmaceutical Excipients Market, by Formulations, 2022-2030
10.1.1. Topical Formulations
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Oral Formulations
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Parenteral Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmaceutical Excipients Market, By End-Users
11.1. Pharmaceutical Excipients Market, by End-Users, 2022-2030
11.1.1. Pharmaceuticals Companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Research Organization
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Academics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Pharmaceutical Excipients Market, By Distribution Channel
12.1. Pharmaceutical Excipients Market, by Distribution Channel, 2022-2030
12.1.1. Online Pharmacy
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Retail
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Mail-Order
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.7. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.10. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 14. Company Profiles
14.1. Ashland Global Holdings
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DuPont
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roquette Feres
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Evonik Industries AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Associated British Foods
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Archer Daniels Midland Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lubrizol Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Croda International
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Kerry Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1761
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
